Active — Not RecruitingNot Applicable

Post Market Clinical Follow-up of Dual-mobility Acetabular Cup EUROSCUP MOBILE

France147 participantsStarted 2021-06-01

Plain-language summary

EUROSCUP MOBILE is intended for use in primary and revision total hip replacement surgery. Hip replacement is intended to provide increased patient mobility and reduce pain by replacing the damages hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components. As part of post market vigilance, EUROS will collect data on EUROSCUP MOBILE performances and safety

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient who received EUROSCUP MOBILE. * Patient informed of its participation to the study * Patient aged between 18 and 80 years old (\<80). Exclusion Criteria: * Patient presenting a contraindication to EUROSCUP MOBILE implantation. * Patient who refused to participate to the study * Vulnerable subjects

What they're measuring

Safety of EUROSCUP MOBILE

Timeframe: 1 year

Trial details

NCT IDNCT04993638

SponsorEUROS

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2034-06-01

View on ClinicalTrials.gov More Hip Arthropathy trials